| Literature DB >> 27888056 |
Megan M Weivoda1, Stephanie J Youssef2, Merry Jo Oursler2.
Abstract
Sclerostin, the product of the SOST gene, is a secreted inhibitor of Wnt signaling that is produced by osteocytes to regulate bone formation. While it is often considered an osteocyte-specific protein, SOST expression has been reported in numerous other cell types, including hypertrophic chondrocytes and cementocytes. Of interest, SOST/sclerostin expression is altered in certain pathogenic conditions, including osteoarthritis and rheumatic joint disease, and it is unclear whether sclerostin plays a protective role or whether sclerostin may mediate disease pathogenesis. Therefore, as anti-sclerostin antibodies are being developed for the treatment of osteoporosis, it is important to understand the functions of sclerostin beyond the regulation of bone formation.Entities:
Keywords: Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis; Sclerostin; Wnt
Mesh:
Substances:
Year: 2016 PMID: 27888056 PMCID: PMC5328839 DOI: 10.1016/j.bone.2016.11.024
Source DB: PubMed Journal: Bone ISSN: 1873-2763 Impact factor: 4.398